Tempus Labs Revenue and Competitors

Chicago, IL USA

Location

$1.1B

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tempus Labs's estimated annual revenue is currently $650.8M per year.(i)
  • Tempus Labs received $110.0M in venture funding in August 2018.
  • Tempus Labs's estimated revenue per employee is $248,000
  • Tempus Labs's total funding is $1.1B.
  • Tempus Labs's current valuation is $8B. (September 2021)

Employee Data

  • Tempus Labs has 2624 Employees.(i)
  • Tempus Labs grew their employee count by 35% last year.

Tempus Labs's People

NameTitleEmail/Phone
1
Head SchoolReveal Email/Phone
2
Senior Manager, Customer ExperienceReveal Email/Phone
3
Principal BiostatisticianReveal Email/Phone
4
Product DesignerReveal Email/Phone
5
High School Librarian/Extended Essay CoordinatorReveal Email/Phone
6
Key Account Director, Global Strategic PartnershipsReveal Email/Phone
7
Molecular Technologist IIReveal Email/Phone
8
MS Social Studies TeacherReveal Email/Phone
9
EAL TeacherReveal Email/Phone
10
Sample Returns SupervisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M18-14%N/AN/A
#2
$0.8M50%N/AN/A
#3
$2M130%N/AN/A
#4
$707.3M285214%$1.1BN/A
#5
$1.7M110%N/AN/A
#6
$32.6M2106%N/AN/A
#7
$2.6M176%N/AN/A
#8
$1.1M7-30%N/AN/A
#9
$1.4M9-10%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Tempus Labs?

Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and analyze molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data. For more information, visit tempus.com and visit us on Facebook (Tempus Labs) and Twitter (@TempusLabs). For more information on Eric Lefkofsky, visit lefkofsky.com.

keywords:saas

$1.1B

Total Funding

2624

Number of Employees

$650.8M

Revenue (est)

35%

Employee Growth %

$8B

Valuation

N/A

Accelerator

Tempus Labs News

2022-04-17 - Precision Medicine Software Industry Market Production ...

... Abbott Laboratories(US), Allscripts(US), Fabric Genomics (US), ... Roper Technologies(US), Tempus Labs Inc (US), Foundation Medicine Inc...

2022-04-17 - Precision Medicine Software Industry Market Production ...

... Abbott Laboratories(US), Allscripts(US), Fabric Genomics (US), ... Roper Technologies(US), Tempus Labs Inc (US), Foundation Medicine Inc...

2022-03-30 - Illinois Dems corner Republicans on abortion rights

Bill Haterty's senior comms adviser Julia Hahn, former American Airlines exec Bill Hood, Tempus Labs' customer experience senior manager...

2022-03-30 - Illinois Dems corner Republicans on abortion rights

Bill Haterty's senior comms adviser Julia Hahn, former American Airlines exec Bill Hood, Tempus Labs' customer experience senior manager...

2021-09-09 - Cedars-Sinai Cancer Launches ‘Molecular Twin’ Initiative for Precision Cancer Treatment

What You Should Know: – Cedars-Sinai Cancer and Tempus, a provider of artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas of patients’ DNA, RNA, protein and other information to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$991.9M2624-3%N/A
#2
$1060M26800%$75.4M
#3
$1013.4M2681N/AN/A
#4
$300M26836%N/A
#5
$1180M27006%N/A

Tempus Labs Funding

DateAmountRoundLead InvestorsReference
2017-09-26$70.0MCNew Enterprise AssociatesArticle
2018-03-21$80.0MUndisclosedT. Rowe PriceArticle
2018-08-30$110.0MEBaillie GiffordArticle